Abstract:Background: Black-White mortality disparities are well-established and continue to widen over time among women diagnosed with endometrial cancer (EC). Yet, few studies have explored the existence or sources of racial/ethnic disparities in EC survival among Hispanic, American Indian/Alaska Native (AI/AN), Asian, and Native-Hawaiian/Pacific Islander (NH/PI) women. EC survival disparities across racial and ethnic groups have been suggested to be linked to differences in sociodemographic, clinical, and access to care characteristics. We examined how these individual- and area-level factors influence the presence of racial/ethnic disparities among women with EC. Methods: Participants were diagnosed between 2004 and 2019 with stages 1A through 4B endometroid and non-endometroid EC in the National Cancer Database (NCDB). Race was categorized as non-Hispanic white (NHW), non-Hispanic black (NHB), Hispanic, Asian, NH/PI, and AI/AN. We performed Oaxaca-Blinder decompositions of the log overall survival (OS) time assuming an accelerated failure time model with Weibull error, which decomposes observed differences in log survival time into parts potentially explained by differences in measured prognostic factors and differences not explained by measured variables. We examined the following classes of prognostic factors: age at diagnosis, zip code-level demographics (educational attainment, average income, and rurality), access to care (insurance status, facility type and location, treatment delay), Charlson comorbidity score, tumor characteristics (stage and histology), and guideline-concordant treatment (GCT). White women were the comparison group in all decompositions. Results: Compared with NHW women (N=121,069; estimated overall survival for average covariates values (eOS)=19.7 years) eOS was significantly shorter among NHB women (N=15,855; eOS=9.9 years); longer among Asian women (N=5,098; eOS=42.7 years); longer among Hispanic women (N=9,671; eOS=25.9 years); and not significantly different in NH/PI (N=536; eOS=24.8 years) or AI/AN women (N=551; eOS=17.0 years). Measured covariates explained 76.7% of the difference for NHB women (p<0.001); 19.7% for Asian women (p<0.001); and did not significantly explain the difference for Hispanic women (8.4%; p=0.14). Factors significantly contributing to the observed differences for NHB women were tumor characteristics (61.5%); access to care (6.6%); zip code-level demographics (5.1%); comorbidity (3.9%); age (-1.8%); and GCT (1.5%). Significant factors for Asian women were age (16.6%); tumor characteristics (-6.0%); zip code-level demographics (4.7%); access to care (3.0%); and comorbidity (1.6%). Significant factors for Hispanic women were age (45.2%); tumor characteristics (-17.9%); access to care (-13.4%); comorbidity (-2.0%); and GCT (-1.0%). Conclusions: Contributors to EC survival disparities vary by race/ethnicity and strongly implicate the need for research to identify how disparities arise to tailor interventions to reduce survival gaps. Citation Format: Jordyn A. Brown, Jennifer A. Sinnott, Ziyu Gao, Caitlin E. Meade, Macarius M. Donneyong, Tasleem J. Padamsee, Ashley S. Felix. Decomposing racial and ethnic disparities in endometrial cancer survival [abstract]. In: Proceedings of the AACR Special Conference on Endometrial Cancer: Transforming Care through Science; 2023 Nov 16-18; Boston, Massachusetts. Philadelphia (PA): AACR; Clin Cancer Res 2024;30(5_Suppl) nr A003.

Racial Disparities in Surgical Outcomes Among Women with Endometrial Cancer

Impact of Race and Ethnicity on Perioperative Outcomes During Hysterectomy for Endometriosis.

Racioethnic Disparities in Endometrial Cancer Outcomes

Abstract A003: Decomposing racial and ethnic disparities in endometrial cancer survival

Racial/ethnic inequities in care for patients with advanced endometrial cancer: What's structural racism and social determinants of health got to do with it?

Associations between race and ethnicity and perioperative outcomes among women undergoing hysterectomy for adenomyosis

Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study

Endometrial Cancer Type 2 Incidence and Survival Disparities Within Subsets of the US Black Population

Correlation of cardiovascular disease with racial disparities in endometrial cancer outcomes.

Abstract IA009: Racial disparities in high grade endometrial cancers

Abstract A006: Performance of the laparoscopic hysterectomy readmission score among diverse women with endometrial cancer

Taking the "in" out of incontinence.

Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials

Abstract IA008: Racial disparities in guideline-concordant endometrial cancer treatment

Racial and Geographic Differences in Endometrial Cancer Death

The mechanism of steroid-hormone regulation of transcription of specific eukaryotic genes.

Abstract C119: Rising incidence and racial disparities of early-onset endometrial cancer in the United States, 1995-2018

Abstract IA010: Neighborhood socioeconomic status and outcomes of patients with endometrial cancer

Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypes

Patterns and trends in the cause of death for patients with endometrial cancer

Rural–urban differences in surgical treatment, regional lymph node examination, and survival in endometrial cancer patients